Many stores are no longer open on Thanksgiving - but fear not, avid holiday shoppers! Here's when they'll open their doors on ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

In an interview with The U.S. Sun, Social Security Advisors CEO Matthew Allen said it’s possible for retirees to get the ...

Ozempic, a weight loss drug that has exploded in use across America, has joined a list of treatments that started with benign intentions and evolved into a reflection of the modern weight loss and ...

Novo Nordisk has launched its blockbuster Wegovy weight-loss drug in China, adding the world’s second-largest economy to its ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention, and more than half a million Americans have a stroke every year. But up ...

According to a 2024 Northwestern Mutual survey, many Americans consider $1.46 million as the “magic number” for a comfortable ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

WASHINGTON, D.C. – Whether insurers cover weight loss drugs like Ozempic is ... and head of claims at Security Mutual Life Insurance Company of New York. One study showed that after one year, half of ...

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan ... About 42 percent of US adults have obesity—that's more than 100 million people—and 9 percent (more ...